https://www.stockstelegraph.com/dt-midstream-inc-dtm-overweight-rating-signals-confidence-amid-volatile-trading https://www.stockstelegraph.com/centerspace-csr-receives-buy-rating-with-upside-potential-surging-to-80 https://www.stockstelegraph.com/the-cooper-companies-inc-coo-piper-sandler-assigns-neutral-rating-with-positive-upside-potential https://www.stockstelegraph.com/caseys-general-stores-inc-casy-receives-outperform-rating-with-750-price-target https://www.stockstelegraph.com/yum-brands-inc-yum-initiated-with-overweight-rating-upside-potential-estimated-at-20-5 https://www.stockstelegraph.com/block-inc-xyz-analyst-upgrade-signals-potential-upside-in-value https://www.stockstelegraph.com/synopsys-inc-snps-upgraded-to-overweight-by-wells-fargo-promising-outlook-ahead https://www.stockstelegraph.com/simmons-first-national-corporation-sfnc-receives-outperform-rating-with-13-upside-potential https://www.stockstelegraph.com/paccar-inc-pcar-rated-outperform-by-rbc-capital-positive-outlook-ahead https://www.stockstelegraph.com/orchestra-biomed-holdings-inc-obio-receives-buy-rating-from-btig-with-significant-upside-potential https://www.stockstelegraph.com/novartis-ag-nvs-hold-rating-from-hsbc-with-price-target-at-136 https://www.stockstelegraph.com/meta-platforms-inc-meta-receives-overweight-rating-with-upside-potential https://www.stockstelegraph.com/herc-holdings-inc-hri-overweight-rating-suggests-significant-upside-potential https://www.stockstelegraph.com/chewy-inc-chwy-in-line-rating-from-evercore-isi-points-to-potential-upside https://www.stockstelegraph.com/caterpillar-inc-cat-receives-buy-rating-with-price-target-of-980 https://www.stockstelegraph.com/biocryst-pharmaceuticals-inc-bcrx-receives-sector-perform-rating-price-target-set-at-13 https://www.stockstelegraph.com/amgen-inc-amgn-rated-hold-with-price-target-of-445-implications-for-investors https://www.stockstelegraph.com/ugi-corporation-ugi-receives-buy-rating-from-jefferies-analyst-sees-upside-potential https://www.stockstelegraph.com/summit-therapeutics-inc-smmt-a-new-buy-rating-signals-upside-potential-amid-mixed-performance https://www.stockstelegraph.com/lineage-inc-line-upgraded-to-overweight-by-morgan-stanley-target-price-of-47-signals-strong-upside-potential https://www.stockstelegraph.com/westlake-corporation-wlk-market-perform-rating-signals-caution https://www.stockstelegraph.com/waters-corporation-wat-receives-buy-rating-from-ubs-price-target-set-at-490 https://www.stockstelegraph.com/vulcan-materials-company-vmc-rating-shift-to-underweight-by-wells-fargo-what-it-means-for-investors https://www.stockstelegraph.com/sagimet-biosciences-inc-sgmt-secures-overweight-rating-by-barclays-analysts-eye-upside-potential https://www.stockstelegraph.com/martin-marietta-materials-inc-mlm-earns-overweight-rating-amid-positive-analyst-outlook https://www.stockstelegraph.com/illumina-inc-ilmn-ubs-initiates-buy-rating-with-a-price-target-of-260 https://www.stockstelegraph.com/figure-technology-solutions-inc-figr-receives-neutral-rating-from-b-of-a-securities-an-investors-analysis https://www.stockstelegraph.com/eagle-materials-inc-exp-wells-fargo-upgrades-to-equal-weight-with-target-price-of-231 https://www.stockstelegraph.com/dyne-therapeutics-inc-dyn-analyst-rating-downgrade-highlights-continued-volatility https://www.stockstelegraph.com/amrize-ltd-amrz-wells-fargo-downgrades-to-equal-weight-as-stock-faces-price-pressure https://www.stockstelegraph.com/zions-bancorporation-zion-downgraded-to-underweight-by-morgan-stanley-short-term-outlook-remains-cautious https://www.stockstelegraph.com/synopsys-inc-snps-receives-overweight-rating-from-morgan-stanley-amidst-positive-earnings-surprise https://www.stockstelegraph.com/simmons-first-national-corporation-sfnc-downgraded-to-underweight-market-outlook-adjusted https://www.stockstelegraph.com/peloton-interactive-inc-pton-morgan-stanley-downgrades-to-underweight-amid-market-concerns https://www.stockstelegraph.com/prosperity-bancshares-inc-pb-rated-underweight-by-morgan-stanley-analyst-raises-concerns-over-growth-prospects https://www.stockstelegraph.com/bank-ozk-ozk-downgraded-to-underweight-analyst-outlook-and-market-prospects https://www.stockstelegraph.com/old-dominion-freight-line-inc-odfl-receives-buy-rating-from-citigroup-amid-positive-earnings-outlook https://www.stockstelegraph.com/mt-bank-corporation-mtb-analyst-upgrade-signals-promising-upside https://www.stockstelegraph.com/intel-corp-intc-analyst-upgrade-signals-strong-upside-potential https://www.stockstelegraph.com/flagstar-financial-inc-flg-receives-overweight-rating-from-morgan-stanley-analysts-see-upside-potential https://www.stockstelegraph.com/east-west-bancorp-inc-ewbc-receives-overweight-rating-from-morgan-stanley-target-set-at-160 https://www.stockstelegraph.com/essex-property-trust-inc-ess-mizuho-downgrades-to-neutral-with-price-target-of-308 https://www.stockstelegraph.com/egain-corporation-egan-neutral-rating-with-significant-upside-potential https://www.stockstelegraph.com/customers-bancorp-inc-cubi-receives-underweight-rating-from-morgan-stanley-analysts-see-upside-to-89 https://www.stockstelegraph.com/c-h-robinson-worldwide-inc-chrw-buy-rating-reflects-growth-potential https://www.stockstelegraph.com/cullen-frost-bankers-inc-cfr-strong-upside-potential-with-overweight-rating-from-morgan-stanley https://www.stockstelegraph.com/commerce-bancshares-inc-cbsh-receives-overweight-rating-from-morgan-stanley-signaling-strong-upside-potential https://www.stockstelegraph.com/central-bancompany-cbc-receives-equal-weight-rating-from-morgan-stanley-price-target-set-at-36 https://www.stockstelegraph.com/airbnb-inc-abnb-receives-outperform-rating-with-price-target-of-200 https://www.stockstelegraph.com/vivmark-residential-vmrk-rating-boosted-to-outperform-with-target-price-of-73 https://www.stockstelegraph.com/tscan-therapeutics-inc-tcrx-neutral-rating-assigned-price-target-indicates-upside-potential https://www.stockstelegraph.com/sensata-technologies-holding-plc-st-upgrade-signals-growth-potential-with-price-target-of-55 https://www.stockstelegraph.com/sweetgreen-inc-sg-upgraded-to-overweight-with-price-target-of-9 https://www.stockstelegraph.com/magnolia-oil-gas-corporation-mgy-upgraded-to-overweight-by-jp-morgan-promising-potential-ahead https://www.stockstelegraph.com/lockheed-martin-corporation-lmt-ubs-upgrades-to-buy-with-a-target-of-674 https://www.stockstelegraph.com/gulfport-energy-corp-gpor-faces-downgrade-to-underweight-amid-mixed-market-sentiment https://www.stockstelegraph.com/eaton-corporation-plc-etn-ubs-initiates-buy-rating-with-significant-upside-potential https://www.stockstelegraph.com/echostar-corporation-echo-ubs-flags-stock-with-buy-rating-and-upside-potential https://www.stockstelegraph.com/doximity-inc-docs-receives-hold-rating-from-freedom-capital-markets-amid-subdued-market-performance https://www.stockstelegraph.com/dauch-corp-dch-earns-buy-rating-from-td-cowen-strong-upside-potential-ahead https://www.stockstelegraph.com/biontech-se-bntx-receives-market-perform-rating-amidst-moderate-price-movements https://www.stockstelegraph.com/biohaven-ltd-bhvn-rbc-capital-downgrades-to-sector-perform-amid-ongoing-volatility https://www.stockstelegraph.com/best-buy-co-inc-bby-receives-neutral-rating-from-da-davidson-amid-sluggish-performance https://www.stockstelegraph.com/amgen-inc-amgn-receives-market-perform-rating-price-target-set-at-450 https://www.stockstelegraph.com/autoliv-inc-alv-holds-steady-with-new-rating-analysts-see-upside-potential https://www.stockstelegraph.com/asbury-automotive-group-inc-abg-strong-buy-rating-with-significant-upside-potential https://www.stockstelegraph.com/simmons-first-national-corporation-sfnc-overweight-rating-signals-upside-potential https://www.stockstelegraph.com/w-p-carey-inc-wpc-equal-weight-rating-suggests-cautious-optimism-amid-solid-fundamentals https://www.stockstelegraph.com/sonida-senior-living-inc-snda-upgraded-to-outperform-with-significant-upside-potential https://www.stockstelegraph.com/uipath-inc-path-analysts-maintain-hold-rating-amid-market-uncertainty https://www.stockstelegraph.com/ormat-technologies-inc-ora-rating-update-reflects-stable-outlook-amid-price-upside-potential https://www.stockstelegraph.com/ha-sustainable-infrastructure-capital-inc-hasi-ubs-neutral-rating-signals-cautious-optimism https://www.stockstelegraph.com/duluth-holdings-inc-dlth-neutral-rating-reflects-stabilized-outlook-price-target-set-at-5 https://www.stockstelegraph.com/zto-express-zto-receives-neutral-rating-from-jp-morgan-a-cautious-approach-amidst-fluctuating-market-conditions https://www.stockstelegraph.com/ultragenyx-pharmaceutical-inc-rare-analyst-downgrade-signals-mixed-outlook https://www.stockstelegraph.com/envista-holdings-corp-nvst-jp-morgan-upgrades-to-overweight-with-strong-upside-potential https://www.stockstelegraph.com/fluence-energy-inc-flnc-rated-underweight-by-barclays-analysts-caution-signals-an-uncertain-outlook https://www.stockstelegraph.com/deere-company-de-upgraded-to-outperform-by-evercore-isi-strong-growth-potential-ahead https://www.stockstelegraph.com/copart-inc-cprt-upgraded-to-overweight-analysts-see-potential-upside https://www.stockstelegraph.com/cnh-industrial-n-v-cnh-earns-outperform-rating-from-evercore-isi-group https://www.stockstelegraph.com/broadcom-inc-avgo-rated-outperform-analyst-sees-upside-potential-amidst-market-volatility https://www.stockstelegraph.com/argan-inc-agx-secures-buy-rating-from-lake-street-strong-upside-ahead https://www.stockstelegraph.com/tscan-therapeutics-inc-tcrx-neutral-rating-issued-amid-market-volatility https://www.stockstelegraph.com/sonoco-products-company-son-receives-neutral-rating-from-b-of-a-securities https://www.stockstelegraph.com/ultragenyx-pharmaceutical-inc-rare-rating-change-in-context-of-recent-declines-and-recovery-potential https://www.stockstelegraph.com/pge-corporation-pcg-maintaining-hold-with-growth-potential https://www.stockstelegraph.com/moderna-inc-mrna-receives-sell-rating-from-rothschild-co-what-investors-should-know https://www.stockstelegraph.com/covista-inc-cvsa-analysts-call-for-hold-amidst-steady-price-targets https://www.stockstelegraph.com/nio-inc-nio-jp-morgan-downgrades-to-neutral-price-target-remains-at-7 https://www.stockstelegraph.com/martin-marietta-materials-inc-mlm-analyst-upgrades-to-overweight-with-strong-upside-potential https://www.stockstelegraph.com/knife-river-corporation-knf-downgraded-to-underweight-investor-sentiment-weighs https://www.stockstelegraph.com/amrize-ltd-amrz-jp-morgan-issues-neutral-rating-significant-upside-potential-remains https://www.stockstelegraph.com/sirius-xm-holdings-inc-siri-receives-buy-rating-with-significant-upside-potential https://www.stockstelegraph.com/oge-energy-corp-oge-positive-rating-change-indicates-upside-potential https://www.stockstelegraph.com/matador-resources-company-mtdr-wells-fargo-upgrades-to-overweight-significant-upside-potential-ahead https://www.stockstelegraph.com/eyepoint-pharmaceuticals-inc-eypt-hold-rating-from-td-cowen-price-target-of-20-indicates-upside-potential https://www.stockstelegraph.com/five-below-inc-five-hold-rating-from-loop-capital-signals-caution-amid-price-corrections https://www.stockstelegraph.com/beam-global-beem-receives-hold-rating-amidst-price-volatility https://www.stockstelegraph.com/rli-corp-rli-downgraded-to-underperform-analyst-calls-for-caution https://www.stockstelegraph.com/shift4-payments-inc-four-upgraded-to-overweight-by-wells-fargo-catalyst-for-growth https://www.stockstelegraph.com/teleflex-incorporated-tfx-receives-overweight-rating-from-piper-sandler-signaling-positive-outlook https://www.stockstelegraph.com/mge-energy-inc-mgee-analysts-upgrade-to-buy-targets-7-upside https://www.stockstelegraph.com/kilroy-realty-corporation-krc-receives-outperform-rating-with-42-price-target https://www.stockstelegraph.com/cognizant-technology-solutions-corporation-ctsh-rating-upgrade-signals-strong-upside-potential https://www.stockstelegraph.com/crocs-inc-crox-receives-outperform-rating-analysts-see-upside-potential https://www.stockstelegraph.com/cummins-inc-cmi-receives-buy-rating-from-ubs-with-strong-upside-potential https://www.stockstelegraph.com/avis-budget-group-inc-car-gets-an-equal-weight-rating-by-barclays-a-complex-landscape-for-investors https://www.stockstelegraph.com/biogen-inc-biib-new-buy-rating-from-needham-highlights-strong-upside-potential https://www.stockstelegraph.com/shattuck-labs-inc-sttk-receives-buy-rating-from-citigroup-driving-upside-potential https://www.stockstelegraph.com/lululemon-athletica-inc-lulu-receives-hold-rating-amidst-mixed-market-signals https://www.stockstelegraph.com/kanzhun-limited-bz-receives-outperform-rating-with-upside-potential https://www.stockstelegraph.com/tesla-inc-tsla-receives-neutral-rating-from-jp-morgan-a-mixed-outlook-for-investors https://www.stockstelegraph.com/formfactor-inc-form-receives-outperform-rating-with-significant-upside-potential https://www.stockstelegraph.com/chipotle-mexican-grill-inc-cmg-receives-overweight-rating-from-jp-morgan-as-market-eyes-upside-potential https://www.stockstelegraph.com/virco-mfg-corporation-virc-receives-hold-rating-with-price-target-of-6-50 https://www.stockstelegraph.com/venture-global-inc-vg-receives-overweight-rating-from-jp-morgan-eyes-significant-upside-potential https://www.stockstelegraph.com/rtx-corporation-rtx-analysts-upgrade-rating-with-significant-upside-potential https://www.stockstelegraph.com/plains-gp-holdings-l-p-pagp-goldman-sachs-assigns-neutral-rating-amidst-mixed-earnings-outlook https://www.stockstelegraph.com/plains-all-american-pipeline-l-p-paa-recent-neutral-rating-signals-stabilization-ahead https://www.stockstelegraph.com/ehang-holdings-limited-eh-ubs-assigns-neutral-rating-amidst-mixed-performance https://www.stockstelegraph.com/cms-energy-corporation-cms-maintains-hold-rating-amidst-steady-market-activity https://www.stockstelegraph.com/broadcom-inc-avgo-receives-neutral-rating-analysts-weigh-in-on-recent-outlook https://www.stockstelegraph.com/unitedhealth-group-incorporated-unh-analyst-upgrade-sets-buy-rating-with-an-eye-on-450-target https://www.stockstelegraph.com/pvh-corp-pvh-in-line-rating-amid-price-volatility-suggests-caution-for-investors https://www.stockstelegraph.com/ollies-bargain-outlet-holdings-inc-olli-accumulate-rating-signals-upside-potential https://www.stockstelegraph.com/murphy-oil-corporation-mur-receives-overweight-rating-from-keybanc-with-promising-upside-potential https://www.stockstelegraph.com/medtronic-plc-mdt-receives-buy-rating-from-btig-upholding-investor-optimism https://www.stockstelegraph.com/erasca-inc-eras-receives-neutral-rating-amid-market-volatility-potential-upside-remains https://www.stockstelegraph.com/commercial-metals-company-cmc-rating-update-reveals-equal-weight-prospects-amid-mixed-earnings https://www.stockstelegraph.com/anterix-inc-atex-receives-a-neutral-rating-from-b-riley-short-term-upside-potential-remains https://www.stockstelegraph.com/adc-therapeutics-s-a-adct-receives-sector-perform-rating-amid-market-struggles https://www.stockstelegraph.com/yum-brands-inc-yum-upgraded-to-overweight-by-morgan-stanley-amid-positive-earnings-surprise https://www.stockstelegraph.com/ssr-mining-inc-ssrm-analyst-upgrade-sparks-optimism-as-price-target-reaches-40 https://www.stockstelegraph.com/rezolute-inc-rzlt-receives-market-outperform-rating-analysts-see-significant-upside https://www.stockstelegraph.com/aveanna-healthcare-holdings-inc-avah-receives-outperform-rating-with-upside-potential https://www.stockstelegraph.com/acadia-healthcare-company-inc-achc-analyst-upgrade-signals-potential-recovery-ahead https://www.stockstelegraph.com/3-stocks-showing-early-price-action-p3-health-partners-piii-sintx-technologies-sint-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-that-could-see-trading-interest-vivos-therapeutics-vvos-cardiol-therapeutics-crdl-dare-bioscience-dare https://www.stockstelegraph.com/3-stocks-that-could-get-active-cardiol-therapeutics-crdl-silexion-therapeutics-slxn-can-fite-biopharma-canf https://www.stockstelegraph.com/nu-holdings-ltd-nu-receives-underperform-rating-from-bofa-securities-amid-deteriorating-outlook https://www.stockstelegraph.com/3-stocks-showing-steady-interest-pharmacyte-biotech-pmcb-cardiol-therapeutics-crdl-processa-pharmaceuticals-pcsa https://www.stockstelegraph.com/3-stocks-that-could-attract-market-eyes-cardiol-therapeutics-crdl-nasus-pharma-nsrx-intensity-therapeutics-ints https://www.stockstelegraph.com/3-stocks-worth-keeping-track-of-envue-medical-feed-focaltherics-focl-cardiol-therapeutics-crdl https://www.stockstelegraph.com/essex-property-trust-inc-ess-evercore-isi-group-initiates-outperform-rating-with-upside-potential https://www.stockstelegraph.com/caesars-entertainment-inc-czr-achieves-neutral-rating-amid-volatile-trading https://www.stockstelegraph.com/campbell-soup-company-cpb-equal-weight-rating-reflects-caution-amid-price-pressures https://www.stockstelegraph.com/grupo-cibest-s-a-cib-receives-neutral-rating-from-b-of-a-securities-amidst-growth-potential https://www.stockstelegraph.com/acv-auctions-inc-acva-achieves-market-perform-rating-with-upside-potential https://www.stockstelegraph.com/zscaler-inc-zs-receives-buy-rating-from-guggenheim-points-to-significant-upside-potential https://www.stockstelegraph.com/tandem-diabetes-care-inc-tndm-receives-overweight-rating-from-wells-fargo-potential-upside-ahead https://www.stockstelegraph.com/redwire-corporation-rdw-receives-hold-rating-from-jefferies https://www.stockstelegraph.com/kohls-corporation-kss-analyst-upgrade-sparks-positive-momentum https://www.stockstelegraph.com/federal-realty-investment-trust-frt-outperform-rating-highlights-upside-potential https://www.stockstelegraph.com/equity-residential-eqr-evercore-isi-assigns-in-line-rating-with-upside-potential https://www.stockstelegraph.com/dell-technologies-inc-dell-receives-equal-weight-rating-from-morgan-stanley-upside-potential-remains https://www.stockstelegraph.com/caesars-entertainment-inc-czr-receives-hold-rating-from-deutsche-bank-amid-mixed-market-signals https://www.stockstelegraph.com/corsair-gaming-inc-crsr-analysts-downgrade-to-hold-amid-price-target-adjustments https://www.stockstelegraph.com/cno-financial-group-inc-cno-in-line-rating-signals-potential-stability-ahead https://www.stockstelegraph.com/blacksky-technology-inc-bksy-receives-hold-rating-from-jefferies-amid-volatile-market-trends https://www.stockstelegraph.com/accenture-plc-acn-analysts-adjust-outlook-to-hold-amid-fluctuating-market-sentiments https://www.stockstelegraph.com/3-stocks-worth-watching-for-changes-adagio-medical-adgm-american-shared-hospital-services-ams-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-that-could-draw-buyers-iridex-irix-cardiol-therapeutics-crdl-elutia-elut https://www.stockstelegraph.com/3-stocks-showing-positive-trends-cardiol-therapeutics-crdl-fibrobiologics-fblg-scienture-scnx https://www.stockstelegraph.com/caesars-entertainment-inc-czr-analyst-upgrades-rating-to-hold-amid-price-stability https://www.stockstelegraph.com/the-gap-inc-gap-analyst-shift-to-neutral-price-target-indicates-potential-upside https://www.stockstelegraph.com/caesars-entertainment-inc-czr-receives-hold-rating-amid-mixed-performance https://www.stockstelegraph.com/ast-spacemobile-inc-asts-receives-hold-rating-from-deutsche-bank-amidst-significant-price-decline https://www.stockstelegraph.com/xpeng-inc-xpev-rated-outperform-analyst-sees-upside-potential https://www.stockstelegraph.com/essential-utilities-inc-wtrg-strong-buy-rating-from-ubs-suggests-promising-upside https://www.stockstelegraph.com/valvoline-inc-vvv-rated-neutral-by-jp-morgan-evaluating-the-outlook https://www.stockstelegraph.com/sensata-technologies-holding-plc-st-analyst-upgrades-to-equal-weight-anticipating-upside-potential https://www.stockstelegraph.com/snowflake-inc-snow-secures-buy-rating-from-hsbc-strong-growth-potential-ahead https://www.stockstelegraph.com/sentinelone-inc-s-receives-buy-rating-from-bofa-securities-analysts-eye-upside-potential https://www.stockstelegraph.com/rollins-inc-rol-receives-market-perform-rating-from-bernstein-growth-potential-remains https://www.stockstelegraph.com/grid-dynamics-holdings-inc-gdyn-jefferies-downgrades-to-hold-amid-mixed-performance https://www.stockstelegraph.com/the-gap-inc-gap-rating-change-to-in-line-with-price-target-of-20 https://www.stockstelegraph.com/equity-residential-eqr-neutral-rating-signals-cautious-outlook-amid-market-fluctuations https://www.stockstelegraph.com/epam-systems-inc-epam-rated-hold-by-jefferies-price-target-suggested-at-110 https://www.stockstelegraph.com/everforth-inc-efor-hold-rating-assigned-with-limited-upside-potential https://www.stockstelegraph.com/dell-technologies-inc-dell-analysts-upgrade-to-positive-with-major-upside-potential https://www.stockstelegraph.com/caesars-entertainment-inc-czr-neutral-rating-from-jp-morgan-reflects-investor-caution https://www.stockstelegraph.com/charles-river-laboratories-international-inc-crl-receives-outperform-rating-with-strong-upside-potential https://www.stockstelegraph.com/cogent-communications-holdings-inc-ccoi-neutral-rating-amidst-market-struggles https://www.stockstelegraph.com/best-buy-co-inc-bby-analyst-rating-shift-to-neutral-amidst-market-volatility https://www.stockstelegraph.com/american-water-works-company-inc-awk-receives-boost-to-buy-rating-amid-promising-price-target https://www.stockstelegraph.com/3-stocks-that-could-pick-up-steam-cardiol-therapeutics-crdl-autonomix-medical-amix-regentis-biomaterials-rgnt https://www.stockstelegraph.com/3-stocks-gaining-traction-in-markets-tevogen-bio-tvgn-cardiol-therapeutics-crdl-newcelx-ncel https://www.stockstelegraph.com/3-stocks-that-could-react-soon-polyrizon-plrz-innovative-eyewear-lucy-cardiol-therapeutics-crdl https://www.stockstelegraph.com/advanced-drainage-systems-inc-wms-upgraded-to-overweight-target-price-of-175-suggests-significant-upside https://www.stockstelegraph.com/westlake-corporation-wlk-citigroup-assigns-neutral-rating-amidst-mixed-performance https://www.stockstelegraph.com/winnebago-industries-inc-wgo-receives-neutral-rating-from-citigroup-amidst-market-volatility https://www.stockstelegraph.com/verra-mobility-corporation-vrrm-receives-hold-rating-from-deutsche-bank-amidst-mixed-market-dynamics https://www.stockstelegraph.com/bbb-foods-inc-tbbb-receives-buy-rating-from-hsbc-target-price-highlights-potential-upside https://www.stockstelegraph.com/td-synnex-corporation-snx-jp-morgan-upgrades-to-overweight-with-strong-upside-potential https://www.stockstelegraph.com/sandisk-corporation-sndk-receives-overweight-rating-from-barclays-strong-upside-potential-ahead https://www.stockstelegraph.com/digital-turbine-inc-apps-receives-buy-rating-from-b-of-a-securities-analysts-target-price-signals-potential-upside https://www.stockstelegraph.com/sandisk-corporation-sndk-upgraded-to-overweight-positive-investment-outlook https://www.stockstelegraph.com/rpm-international-inc-rpm-upgraded-to-buy-by-ubs-significant-upside-potential-ahead https://www.stockstelegraph.com/3-stocks-worth-following-closely-grace-therapeutics-grce-cardiol-therapeutics-crdl-bioline-rx-blrx https://www.stockstelegraph.com/3-stocks-worth-tracking-now-imunon-imnn-enveric-biosciences-envb-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-that-could-move-soon-cardiol-therapeutics-crdl-aptevo-therapeutics-apvo-onemednet-onmd https://www.stockstelegraph.com/ptc-therapeutics-inc-ptct-receives-buy-rating-from-jefferies-amid-promising-outlook https://www.stockstelegraph.com/phillips-66-psx-receives-outperform-rating-bright-outlook-ahead https://www.stockstelegraph.com/pebblebrook-hotel-trust-peb-receives-buy-rating-from-truist-securities-with-upside-potential https://www.stockstelegraph.com/par-pacific-holdings-inc-parr-receives-outperform-rating-with-strong-upside-potential https://www.stockstelegraph.com/openlane-inc-opln-receives-overweight-rating-analysts-see-upside-potential https://www.stockstelegraph.com/insight-enterprises-inc-nsit-jp-morgan-assigns-neutral-rating-with-upside-potential https://www.stockstelegraph.com/msci-inc-msci-upgraded-to-overweight-analyst-projects-significant-upside-potential https://www.stockstelegraph.com/mgm-resorts-international-mgm-receives-buy-rating-from-truist-securities-amid-optimistic-price-target https://www.stockstelegraph.com/kennametal-inc-kmt-analyst-downgrades-to-underweight-amidst-mixed-performance https://www.stockstelegraph.com/ingram-micro-holding-corporation-ingm-neutral-rating-from-jp-morgan-suggests-limited-upside https://www.stockstelegraph.com/icu-medical-inc-icui-receives-buy-rating-from-needham-amid-positive-earnings-surprise https://www.stockstelegraph.com/the-hershey-company-hsy-analysts-favor-stock-following-upgrade-and-price-target-increase https://www.stockstelegraph.com/here-group-limited-here-neutral-rating-by-citigroup-following-earnings-miss https://www.stockstelegraph.com/gxo-logistics-inc-gxo-achieves-overweight-rating-with-price-target-of-65 https://www.stockstelegraph.com/gulfport-energy-corporation-gpor-upgraded-to-outperform-a-robust-outlook-ahead https://www.stockstelegraph.com/h-b-fuller-company-ful-receives-neutral-rating-from-jp-morgan-analyzing-future-potential https://www.stockstelegraph.com/ferrovial-se-fer-analyst-downgrade-to-neutral-sparks-investor-curiosity https://www.stockstelegraph.com/fedex-corporation-fdx-analysts-upgrade-rating-project-upside-to-460 https://www.stockstelegraph.com/ecolab-inc-ecl-receives-buy-rating-from-ubs-analysts-see-upside-potential https://www.stockstelegraph.com/cdw-corporation-cdw-upgraded-to-overweight-by-jp-morgan-points-to-14-upside-potential https://www.stockstelegraph.com/biontech-se-bntx-receives-buy-rating-from-ubs-with-upside-potential https://www.stockstelegraph.com/zscaler-inc-zs-rating-downgrade-in-line-outlook-from-evercore-isi https://www.stockstelegraph.com/verra-mobility-corporation-vrrm-downgraded-to-underweight-by-jp-morgan-price-target-set-at-8 https://www.stockstelegraph.com/kosmos-energy-ltd-kos-receives-underperform-rating-analyzing-analysts-outlook-and-recent-market-activity https://www.stockstelegraph.com/first-interstate-bancsystem-inc-fibk-receives-neutral-rating-from-da-davidson-what-it-means-for-investors https://www.stockstelegraph.com/hf-sinclair-corporation-dino-receives-neutral-rating-from-mizuho-price-target-suggests-upside-potential https://www.stockstelegraph.com/acnb-corporation-acnb-steady-performance-under-new-market-rating https://www.stockstelegraph.com/3-stocks-that-could-shift-higher-mira-pharmaceuticals-mira-concord-medical-services-ccm-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-on-the-move-lunai-bioworks-lnai-cardiol-therapeutics-crdl-aspire-biopharma-asbp https://www.stockstelegraph.com/3-stocks-showing-market-activity-cardiol-therapeutics-crdl-boundless-bio-bold-nextcure-nxtc https://www.stockstelegraph.com/the-travelers-companies-inc-trv-neutral-rating-from-jp-morgan-with-potential-upside https://www.stockstelegraph.com/the-timken-company-tkr-receives-overweight-rating-from-jp-morgan-target-price-at-150 https://www.stockstelegraph.com/tectonic-therapeutic-inc-tecx-strong-buy-rating-indicates-significant-upside-potential https://www.stockstelegraph.com/occidental-petroleum-corporation-oxy-barclays-upgrades-to-overweight-with-price-target-of-72 https://www.stockstelegraph.com/marvell-technology-inc-mrvl-receives-buy-rating-from-hsbc-price-target-of-300 https://www.stockstelegraph.com/cognex-corporation-cgnx-receives-overweight-rating-from-jp-morgan-with-price-target-of-75 https://www.stockstelegraph.com/booz-allen-hamilton-holding-corporation-bah-analyst-rating-upgraded-to-buy-with-significant-upside-potential https://www.stockstelegraph.com/astrana-health-inc-asth-upgraded-to-overweight-strong-upside-potential-ahead https://www.stockstelegraph.com/allient-inc-alnt-upgrade-to-overweight-signals-optimism-price-target-set-at-80 https://www.stockstelegraph.com/agilon-health-inc-agl-barclays-analysts-shift-to-equal-weight-elevating-price-target-to-81 https://www.stockstelegraph.com/lear-corporation-lea-td-cowen-upgrades-to-buy-with-target-price-of-165 https://www.stockstelegraph.com/cosan-s-a-csan-downgraded-to-reduce-price-target-set-at-3-20 https://www.stockstelegraph.com/baycom-corp-bcml-secures-neutral-rating-with-analyst-price-target-indicating-upside-potential https://www.stockstelegraph.com/3-stocks-showing-consistent-activity-xbiotech-xbit-cue-biopharma-cue-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-that-could-attract-attention-burning-rock-biotech-bnr-cardiol-therapeutics-crdl-dbv-technologies-dbvt https://www.stockstelegraph.com/3-stocks-that-could-gain-ground-cardiol-therapeutics-crdl-adlai-nortye-anl-neurogene-ngne https://www.stockstelegraph.com/dorian-lpg-ltd-lpg-hold-rating-from-freedom-broker-with-upside-potential-to-51 https://www.stockstelegraph.com/futu-holdings-limited-futu-rating-shift-neutral-with-price-target-of-87 https://www.stockstelegraph.com/deckers-outdoor-corporation-deck-neutral-rating-signals-cautious-optimism-with-upward-price-potential https://www.stockstelegraph.com/alcoa-corporation-aa-receives-buy-rating-from-ubs-positive-outlook-ahead https://www.stockstelegraph.com/viking-holdings-ltd-vik-receives-buy-rating-from-truist-securities-target-set-at-102 https://www.stockstelegraph.com/texas-instruments-incorporated-txn-a-compelling-buy-rated-ahead-of-strong-price-upside https://www.stockstelegraph.com/sweetgreen-inc-sg-receives-overweight-rating-as-jp-morgan-sets-price-target-at-13 https://www.stockstelegraph.com/haemonetics-corporation-hae-receives-buy-rating-from-bofa-securities-amidst-strong-earnings-surprise https://www.stockstelegraph.com/generac-holdings-inc-gnrc-receives-buy-rating-with-significant-upside-potential https://www.stockstelegraph.com/endava-plc-dava-downgraded-to-underweight-by-jp-morgan-implications-for-investors https://www.stockstelegraph.com/3-stocks-worth-staying-updated-on-vyne-therapeutics-vyne-scinai-immunotherapeutics-scni-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-showing-early-strength-bluejay-diagnostics-bjdx-cardiol-therapeutics-crdl-matinas-biopharma-mtnb https://www.stockstelegraph.com/3-stocks-worth-following-this-week-cardiol-therapeutics-crdl-milestone-scientific-mlss-jasper-therapeutics-jspr https://www.stockstelegraph.com/walmart-inc-wmt-analyst-rating-shift-to-hold-potential-remains-in-focus https://www.stockstelegraph.com/intuit-inc-intu-receives-hold-rating-amidst-price-correction-and-future-potential https://www.stockstelegraph.com/regional-management-corp-rm-upgraded-to-market-outperform-by-citizens-price-target-set-at-45 https://www.stockstelegraph.com/northern-oil-and-gas-inc-nog-maintains-outperform-rating-with-price-target-upside https://www.stockstelegraph.com/kyndryl-holdings-inc-kd-receives-neutral-rating-amidst-weak-performance https://www.stockstelegraph.com/zoominfo-technologies-inc-gtm-receives-hold-rating-from-jefferies https://www.stockstelegraph.com/ge-healthcare-technologies-inc-gehc-neutral-rating-from-ubs-with-upside-potential https://www.stockstelegraph.com/flywire-corporation-flyw-receives-neutral-rating-amid-price-target-stability https://www.stockstelegraph.com/etsy-inc-etsy-upgraded-to-buy-analyst-sees-significant-upside-potential https://www.stockstelegraph.com/ameren-corporation-aee-jp-morgan-upgrades-to-overweight-with-price-target-of-126 https://www.stockstelegraph.com/3-stocks-worth-watching-for-action-skye-bioscience-skye-cardiol-therapeutics-crdl-atara-biotherapeutics-atra https://www.stockstelegraph.com/3-stocks-showing-signs-of-activity-moleculin-biotech-mbrx-catheter-precision-vtak-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-traders-are-eyeing-cardiol-therapeutics-crdl-ridgetech-rdgt-valion-bio-vbio https://www.stockstelegraph.com/target-corporation-tgt-receives-hold-rating-amid-mixed-sentiment https://www.stockstelegraph.com/sionna-therapeutics-inc-sion-receives-hold-rating-amid-mixed-performance-indicators https://www.stockstelegraph.com/franco-nevada-corporation-fnv-bullish-rating-unveils-strong-upside-potential https://www.stockstelegraph.com/evolution-petroleum-corporation-epm-rating-held-at-hold-amidst-volatility https://www.stockstelegraph.com/atyr-pharma-inc-atyr-receives-buy-rating-with-significant-upside-potential https://www.stockstelegraph.com/ermenegildo-zegna-n-v-zgn-bullish-buy-rating-amid-growth-potential https://www.stockstelegraph.com/sm-energy-company-sm-receives-outperform-rating-from-raymond-james https://www.stockstelegraph.com/rubrik-inc-rbrk-receives-outperform-rating-with-significant-upside-potential https://www.stockstelegraph.com/packaging-corporation-of-america-pkg-ubs-initiates-coverage-with-a-buy-rating https://www.stockstelegraph.com/phreesia-inc-phr-receives-equal-weight-rating-from-wells-fargo-amidst-stock-fluctuations https://www.stockstelegraph.com/ovintiv-inc-ovv-receives-buy-rating-from-citigroup-analysts-see-upside-to-70 https://www.stockstelegraph.com/newell-brands-inc-nwl-downgrade-highlights-concerns-amidst-low-stock-performance https://www.stockstelegraph.com/northern-oil-and-gas-inc-nog-maintains-hold-rating-with-price-target-upside-potential https://www.stockstelegraph.com/humana-inc-hum-deutsche-bank-upgrades-to-buy-with-price-target-of-441 https://www.stockstelegraph.com/gilead-sciences-inc-gild-receives-buy-rating-amid-positive-earnings-surprise-and-strong-analyst-sentiment https://www.stockstelegraph.com/elevance-health-inc-elv-deutsche-bank-upgrades-to-buy-with-significant-upside-potential https://www.stockstelegraph.com/california-resources-corporation-crc-receives-buy-rating-from-citigroup-analysts-see-potential-upside https://www.stockstelegraph.com/centene-corporation-cnc-receives-buy-rating-from-deutsche-bank-analyst-sees-upside-potential https://www.stockstelegraph.com/cigna-corporation-ci-receives-hold-rating-from-deutsche-bank-with-price-target-of-302 https://www.stockstelegraph.com/c-h-robinson-worldwide-inc-chrw-analyst-upgrade-signals-strong-growth-potential https://www.stockstelegraph.com/3-stocks-that-could-see-movement-celularity-celu-ernexa-therapeutics-erna-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-investors-should-watch-enlivex-enlv-cardiol-therapeutics-crdl-cardio-diagnostics-cdio https://www.stockstelegraph.com/3-stocks-showing-promising-activity-cardiol-therapeutics-crdl-aethlon-medical-aemd-check-cap-mbai https://www.stockstelegraph.com/the-hanover-insurance-group-inc-thg-market-perform-rating-amidst-consistent-performance https://www.stockstelegraph.com/stubhub-holdings-inc-stub-receives-buy-rating-from-guggenheim-indicating-strong-upside-potential https://www.stockstelegraph.com/principal-financial-group-inc-pfg-raymond-james-upgrades-to-outperform-with-price-target-of-111 https://www.stockstelegraph.com/stubhub-holdings-inc-stub-a-strong-buy-with-significant-upside-potential https://www.stockstelegraph.com/progyny-inc-pgny-receives-buy-rating-with-significant-upside-potential https://www.stockstelegraph.com/james-river-group-holdings-ltd-jrvr-neutral-rating-from-ubs-signals-caution-amid-mixed-signals https://www.stockstelegraph.com/jazz-pharmaceuticals-plc-jazz-receives-buy-rating-from-ubs-projected-price-target-of-307 https://www.stockstelegraph.com/canadian-solar-inc-csiq-analyst-downgrades-to-hold-with-limited-upside-potential https://www.stockstelegraph.com/biofrontera-inc-bfri-receives-speculative-buy-rating-from-benchmark https://www.stockstelegraph.com/beam-global-beem-analyst-maintains-hold-rating-amid-market-struggles https://www.stockstelegraph.com/credicorp-ltd-bap-analyst-upgrade-signals-buy-opportunity-with-upside-potential https://www.stockstelegraph.com/american-tower-corporation-amt-upgraded-to-outperform-analysts-see-substantial-upside-potential https://www.stockstelegraph.com/assured-guaranty-ltd-ago-achieves-buy-rating-with-upside-potential https://www.stockstelegraph.com/3-stocks-worth-watching-for-change-itonic-itoc-veru-veru-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-that-could-see-interest-rise-acurx-pharmaceuticals-acxp-cardiol-therapeutics-crdl-in8bio-inab https://www.stockstelegraph.com/3-stocks-that-could-make-headlines-cardiol-therapeutics-crdl-sharps-technology-stss-kairos-pharma-kapa https://www.stockstelegraph.com/westlake-corporation-wlk-receives-neutral-rating-from-jp-morgan-implications-for-investors https://www.stockstelegraph.com/viking-holdings-ltd-vik-upgraded-to-overweight-analysts-see-significant-upside-potential https://www.stockstelegraph.com/regeneron-pharmaceuticals-inc-regn-analyst-downgrades-to-market-perform-following-stock-slide https://www.stockstelegraph.com/liveramp-holdings-inc-ramp-da-davidson-rates-stock-neutral-with-upside-potential https://www.stockstelegraph.com/lam-research-corporation-lrcx-earns-overweight-rating-from-morgan-stanley-strong-upside-potential-ahead https://www.stockstelegraph.com/inter-co-inc-intr-receives-neutral-rating-from-citigroup-a-cautious-turn-in-sentiment https://www.stockstelegraph.com/f5-inc-ffiv-receives-outperform-rating-from-evercore-isi-with-upside-potential-to-475 https://www.stockstelegraph.com/deckers-outdoor-corporation-deck-neutral-rating-signals-cautious-approach-amid-market-volatility https://www.stockstelegraph.com/coreweave-inc-crwv-receives-neutral-rating-from-da-davidson-amid-price-contraction https://www.stockstelegraph.com/crown-holdings-inc-cck-receives-overweight-rating-from-jp-morgan-positive-outlook-ahead https://www.stockstelegraph.com/ball-corporation-ball-analysts-upgrade-to-overweight-with-upside-potential https://www.stockstelegraph.com/american-homes-4-rent-amh-analyst-rating-boosts-outlook-with-potential-upside https://www.stockstelegraph.com/applied-materials-inc-amat-receives-equal-weight-rating-from-morgan-stanley-a-balanced-view-ahead https://www.stockstelegraph.com/automatic-data-processing-inc-adp-equal-weight-rating-by-wells-fargo-signals-a-stable-outlook https://www.stockstelegraph.com/3-stocks-drawing-market-focus-moolec-science-mlec-cytomed-therapeutics-gdtc-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-gaining-momentum-in-the-market-curanex-pharmaceuticals-curx-cardiol-therapeutics-crdl-aeon-biopharma-aeon https://www.stockstelegraph.com/3-stocks-worth-checking-out-today-cardiol-therapeutics-crdl-indaptus-therapeutics-indp-bioaffinity-technologies-biaf https://www.stockstelegraph.com/sutro-biopharma-inc-stro-receives-upgrade-to-outperform-from-wedbush-suggesting-significant-upside-potential https://www.stockstelegraph.com/stoneco-ltd-stne-receives-neutral-rating-from-citigroup-analysts-cautious-amid-market-volatility https://www.stockstelegraph.com/avita-medical-inc-rcel-receives-buy-rating-with-positive-outlook-from-analysts https://www.stockstelegraph.com/lifeway-foods-inc-lway-receives-hold-rating-from-freedom-broker-amidst-market-volatility https://www.stockstelegraph.com/genie-energy-ltd-gne-receives-buy-rating-from-freedom-broker-target-price-set-at-16 https://www.stockstelegraph.com/firstenergy-corp-fe-receives-buy-rating-from-td-cowen-highlighting-upside-potential https://www.stockstelegraph.com/eagle-financial-services-inc-efsi-receives-buy-rating-from-freedom-broker-analyst-sees-upside-potential https://www.stockstelegraph.com/cisco-systems-inc-csco-receives-buy-rating-from-hsbc-price-target-implies-upside-potential https://www.stockstelegraph.com/c-h-robinson-worldwide-inc-chrw-citigroup-initiates-a-buy-rating-targeting-21-56-upside https://www.stockstelegraph.com/carter-bankshares-inc-care-receives-hold-rating-limited-upside-potential https://www.stockstelegraph.com/burke-herbert-financial-services-corp-bhrb-analyst-upgrade-sparks-optimism-with-target-price-of-74 https://www.stockstelegraph.com/aveanna-healthcare-holdings-inc-avah-receives-overweight-rating-projected-price-target-suggests-strong-upside-potential https://www.stockstelegraph.com/wix-com-ltd-wix-receives-equal-weight-rating-amidst-mixed-sentiment https://www.stockstelegraph.com/viking-holdings-ltd-vik-receives-equal-weight-rating-from-morgan-stanley-signaling-cautious-investor-sentiment https://www.stockstelegraph.com/texas-roadhouse-inc-txrh-rbc-capital-upgrades-to-outperform-with-strong-upside-potential https://www.stockstelegraph.com/tango-therapeutics-inc-tngx-undergoes-neutral-rating-revision-amid-price-fluctuations https://www.stockstelegraph.com/the-timken-company-tkr-neutral-rating-from-jp-morgan-and-upside-potential-ahead https://www.stockstelegraph.com/rxo-inc-rxo-receives-buy-rating-with-upside-potential-to-22 https://www.stockstelegraph.com/phreesia-inc-phr-receives-equal-weight-rating-analysts-see-moderate-upside https://www.stockstelegraph.com/optimum-communications-inc-optu-downgraded-to-sell-amid-stagnant-growth https://www.stockstelegraph.com/gambling-com-group-limited-gamb-receives-speculative-buy-rating-analyst-predicts-upside-potential https://www.stockstelegraph.com/fermi-inc-frmi-in-line-rating-by-evercore-isi-group-signals-cautious-optimism https://www.stockstelegraph.com/doximity-inc-docs-receives-equal-weight-rating-from-barclays-potential-upside-ahead https://www.stockstelegraph.com/crescent-capital-bdc-inc-ccap-recent-analyst-upgrade-indicates-growth-potential-ahead https://www.stockstelegraph.com/bwx-technologies-inc-bwxt-receives-buy-rating-with-upward-price-target https://www.stockstelegraph.com/a-o-smith-corporation-aos-downgraded-to-underweight-by-jp-morgan-whats-next-for-investors https://www.stockstelegraph.com/alumis-inc-alms-receives-neutral-rating-from-hc-wainwright-analysts-express-caution-amid-price-stability https://www.stockstelegraph.com/allegion-plc-alle-maintains-neutral-rating-amidst-price-target-adjustments https://www.stockstelegraph.com/aardvark-therapeutics-inc-aard-receives-underweight-rating-from-morgan-stanley-amid-adjusted-price-target https://www.stockstelegraph.com/3-stocks-worth-monitoring-this-month-cellectis-clls-alterity-therapeutics-athe-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-making-headlines-today-cardiol-therapeutics-crdl-kala-bio-kala-pelthos-therapeutics-pths https://www.stockstelegraph.com/3-stocks-that-could-surprise-the-market-polypid-pypd-cardiol-therapeutics-crdl-nyxoah-nyxh https://www.stockstelegraph.com/wix-com-ltd-wix-assigned-sector-perform-rating-potential-for-upside-amidst-market-volatility https://www.stockstelegraph.com/tango-therapeutics-inc-tngx-jefferies-assigns-hold-rating-amid-market-volatility https://www.stockstelegraph.com/sangoma-technologies-corporation-sang-analyst-downgrade-to-hold-amid-price-decline https://www.stockstelegraph.com/everpure-inc-p-receives-neutral-rating-from-citigroup-amidst-steady-performance https://www.stockstelegraph.com/doximity-inc-docs-receives-neutral-rating-from-baird-amid-continued-volatility https://www.stockstelegraph.com/autohome-inc-athm-receives-hold-rating-from-hsbc-reflecting-limited-upside-potential https://www.stockstelegraph.com/an2-therapeutics-inc-antx-ratings-upgrade-growth-potential-ahead https://www.stockstelegraph.com/assurant-inc-aiz-gains-overweight-rating-strong-analyst-confidence-with-upside-potential https://www.stockstelegraph.com/wix-com-ltd-wix-citigroup-issues-neutral-rating-amidst-volatile-trading-environment https://www.stockstelegraph.com/whirlpool-corporation-whr-goldman-sachs-assigns-neutral-outlook-with-price-target-of-53 https://www.stockstelegraph.com/staar-surgical-company-staa-receives-outperform-rating-with-significant-upside-potential https://www.stockstelegraph.com/starbucks-corporation-sbux-td-cowen-upgrades-to-buy-with-price-target-of-120 https://www.stockstelegraph.com/mid-america-apartment-communities-inc-maa-downgraded-to-sector-underperform-analysts-signal-caution https://www.stockstelegraph.com/doximity-inc-docs-receives-equal-weight-rating-from-wells-fargo-amid-market-fluctuations https://www.stockstelegraph.com/camden-property-trust-cpt-receives-sector-underperform-rating-from-scotiabank-price-target-set-at-95 https://www.stockstelegraph.com/compass-minerals-international-inc-cmp-neutral-rating-from-jp-morgan-highlights-limited-upside https://www.stockstelegraph.com/commercial-metals-company-cmc-analyst-upgrade-signals-strong-growth-potential-ahead https://www.stockstelegraph.com/the-cheesecake-factory-incorporated-cake-neutral-rating-with-upside-potential https://www.stockstelegraph.com/amphastar-pharmaceuticals-inc-amph-wells-fargo-assigns-equal-weight-rating-amid-sluggish-performance https://www.stockstelegraph.com/3-stocks-showing-bullish-signals-collplant-biotechnologies-clgn-abvc-biopharma-abvc-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-that-could-see-momentum-passage-bio-pasg-cardiol-therapeutics-crdl-scisparc-sprc https://www.stockstelegraph.com/3-stocks-that-could-stand-out-cardiol-therapeutics-crdl-immuron-imrn-retractable-technologies-rvp https://www.stockstelegraph.com/zebra-technologies-corporation-zbra-receives-overweight-rating-signaling-strong-upside-potential https://www.stockstelegraph.com/under-armour-inc-uaa-receives-hold-rating-from-stifel-analysts-eye-a-price-target-of-6 https://www.stockstelegraph.com/sensata-technologies-holding-plc-st-analysts-initiate-buy-rating-amidst-strong-upside-potential https://www.stockstelegraph.com/select-medical-holdings-corporation-sem-receives-neutral-rating-amid-mixed-earnings-outlook https://www.stockstelegraph.com/integer-holdings-corporation-itgr-receives-outperform-rating-with-strong-upside-potential https://www.stockstelegraph.com/zoominfo-technologies-inc-gtm-downgraded-to-underperform-by-mizuho-investors-take-note https://www.stockstelegraph.com/avnet-inc-avt-receives-neutral-rating-from-b-of-a-securities-amidst-mixed-market-sentiment https://www.stockstelegraph.com/arrow-electronics-inc-arw-receives-neutral-rating-amid-positive-earnings-surprise https://www.stockstelegraph.com/akamai-technologies-inc-akam-analyst-upgrades-to-buy-with-price-target-of-175 https://www.stockstelegraph.com/3-stocks-that-could-climb-higher-gh-research-ghrs-nutex-health-nutx-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-catching-market-interest-whitehawk-therapeutics-whwk-cardiol-therapeutics-crdl-ss-innovations-international-ssii https://www.stockstelegraph.com/3-stocks-that-could-move-higher-cardiol-therapeutics-crdl-park-dental-partners-park-valneva-se-valn https://www.stockstelegraph.com/zoominfo-technologies-inc-gtm-piper-sandler-downgrades-to-underweight-price-target-cut-to-4 https://www.stockstelegraph.com/3-stocks-worth-following-right-now-cadrenal-therapeutics-cvkd-cuprina-cupr-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-investors-should-know-about-briacell-therapeutics-bctx-cardiol-therapeutics-crdl-oragenics-inc-ogen https://www.stockstelegraph.com/3-stocks-to-keep-on-your-radar-cardiol-therapeutics-crdl-dyadic-international-dyai-jaguar-health-jagx https://www.stockstelegraph.com/starz-entertainment-corp-strz-receives-outperform-rating-with-a-target-of-30-key-insights-for-investors https://www.stockstelegraph.com/primoris-services-corporation-prim-receives-outperform-rating-significant-upside-potential-identified https://www.stockstelegraph.com/goodyear-tire-rubber-company-gt-rating-change-to-hold-reflects-near-term-challenges https://www.stockstelegraph.com/3-stocks-traders-are-watching-nexgel-nxgl-seastar-medical-icu-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-worth-watching-today-cardiol-therapeutics-crdl-fortress-biotech-fbio-dogwood-therapeutics-dwtx https://www.stockstelegraph.com/3-stocks-that-could-see-big-moves-creative-medical-technology-celz-cardiol-therapeutics-crdl-nexalin-technology-nxl https://www.stockstelegraph.com/agilon-health-inc-agl-analyst-upgrades-to-buy-with-upside-potential https://www.stockstelegraph.com/clear-secure-inc-you-neutral-rating-indicates-limited-upside-potential https://www.stockstelegraph.com/chiron-real-estate-inc-xrn-receives-neutral-rating-as-analysts-see-limited-upside-potential https://www.stockstelegraph.com/united-therapeutics-corporation-uthr-receives-overweight-rating-from-wells-fargo-strong-growth-potential-ahead https://www.stockstelegraph.com/tactile-systems-technology-inc-tcmd-b-riley-securities-upgrades-to-buy-price-target-of-36 https://www.stockstelegraph.com/southwest-gas-holdings-inc-swx-receives-overweight-rating-analysts-see-upside-potential https://www.stockstelegraph.com/sitime-corporation-sitm-receives-overweight-rating-from-barclays-price-target-indicates-room-for-growth https://www.stockstelegraph.com/seadrill-limited-sdrl-barclays-assigns-overweight-rating-with-a-price-target-of-59 https://www.stockstelegraph.com/transocean-ltd-rig-receives-upgraded-rating-from-barclays-analysts-project-significant-upside https://www.stockstelegraph.com/quidelortho-corporation-qdel-hold-rating-assigned-amid-mixed-financial-signals https://www.stockstelegraph.com/paypal-holdings-inc-pypl-neutral-rating-from-macquarie-amidst-mixed-market-performance https://www.stockstelegraph.com/propetro-holding-corp-pump-upgraded-to-overweight-by-barclays-amid-price-target-boost https://www.stockstelegraph.com/prologis-inc-pld-receives-outperform-rating-from-bmo-capital-target-price-at-162 https://www.stockstelegraph.com/noble-corporation-plc-ne-upgraded-to-overweight-analyst-projects-significant-upside-potential https://www.stockstelegraph.com/nabors-industries-ltd-nbr-receives-equal-weight-rating-from-barclays-amidston-volatility https://www.stockstelegraph.com/modiv-industrial-inc-mdv-receives-neutral-rating-amid-subpar-earnings https://www.stockstelegraph.com/lifevantage-corporation-lfvn-analysts-set-hold-rating-price-target-at-5 https://www.stockstelegraph.com/kennametal-inc-kmt-receives-hold-rating-from-jefferies-analysts-cite-upside-potential https://www.stockstelegraph.com/fortinet-inc-ftnt-receives-buy-rating-from-btig-with-upside-potential https://www.stockstelegraph.com/freshpet-inc-frpt-receives-overweight-rating-analysts-see-21-upside-potential https://www.stockstelegraph.com/criteo-s-a-crto-receives-equal-weight-rating-from-wells-fargo-amid-volatile-market-conditions https://www.stockstelegraph.com/cross-country-healthcare-inc-ccrn-neutral-rating-signals-caution-amidst-high-volatility https://www.stockstelegraph.com/brightview-holdings-inc-bv-receives-neutral-rating-from-jp-morgan-price-target-set-at-14 https://www.stockstelegraph.com/amplitude-inc-ampl-analysts-signal-neutral-stance-amidst-volatile-market-conditions https://www.stockstelegraph.com/agilon-health-inc-agl-gets-a-buy-rating-potential-upside-in-a-volatile-market https://www.stockstelegraph.com/alcoa-corporation-aa-receives-overweight-rating-from-wells-fargo-positive-outlook-ahead https://www.stockstelegraph.com/3-stocks-investors-are-watching-cardiol-therapeutics-crdl-lb-pharmaceuticals-lbrx-kazia-therapeutics-kzia https://www.stockstelegraph.com/3-stocks-showing-positive-momentum-leonabio-lona-american-well-amwl-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-showing-market-strength-biodesix-bdsx-cardiol-therapeutics-crdl-pharming-group-phar https://www.stockstelegraph.com/scorpio-tankers-inc-stng-receives-buy-rating-from-bofa-securities-target-price-of-100 https://www.stockstelegraph.com/selective-insurance-group-inc-sigi-receives-outperform-rating-from-bmo-capital-pointing-to-significant-upside-potential https://www.stockstelegraph.com/louisiana-pacific-corporation-lpx-receives-upgrade-to-outperform-strong-upside-potential https://www.stockstelegraph.com/3-stocks-that-could-rally-soon-anbio-biotechnology-nnnn-radiopharm-theranostics-radx-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-worth-tracking-this-week-instil-bio-til-cardiol-therapeutics-crdl-connect-biopharma-cntb https://www.stockstelegraph.com/3-stocks-to-watch-right-now-cardiol-therapeutics-crdl-lixte-biotechnology-lixt-immucell-iccc https://www.stockstelegraph.com/valley-national-bancorp-vly-morgan-stanley-assigns-equal-weight-rating-with-15-price-target https://www.stockstelegraph.com/v-f-corporation-vfc-receives-buy-rating-from-btig-with-23-price-target https://www.stockstelegraph.com/townebank-town-receives-market-perform-rating-upside-potential-matches-current-price https://www.stockstelegraph.com/ipg-photonics-corporation-ipgp-receives-buy-rating-from-needham-amidst-potential-upside https://www.stockstelegraph.com/globalfoundries-inc-gfs-positive-rating-boosts-optimism-amid-market-challenges https://www.stockstelegraph.com/advanced-micro-devices-inc-amd-recent-buy-rating-sparks-optimism-for-stock https://www.stockstelegraph.com/globalfoundries-inc-gfs-receives-positive-rating-upgrade-target-price-set-at-100 https://www.stockstelegraph.com/davita-inc-dva-deutsche-bank-upgrades-to-buy-with-220-price-target https://www.stockstelegraph.com/bellring-brands-inc-brbr-receives-equal-weight-rating-analysts-target-22-upside https://www.stockstelegraph.com/topbuild-corp-bld-receives-neutral-rating-opportunity-or-caution https://www.stockstelegraph.com/franklin-resources-inc-ben-morgan-stanley-assigns-equal-weight-rating-amidst-modest-revival https://www.stockstelegraph.com/ashland-inc-ash-analyst-upgrade-signals-strong-upside-potential https://www.stockstelegraph.com/abercrombie-fitch-co-anf-rating-downgraded-to-underweight-by-barclays https://www.stockstelegraph.com/advanced-micro-devices-inc-amd-goldman-sachs-upgrades-to-buy-with-price-target-of-450 https://www.stockstelegraph.com/american-eagle-outfitters-inc-aeo-receives-equal-weight-rating-from-barclays https://www.stockstelegraph.com/3-stocks-gearing-up-for-a-potential-rally-cardiol-therapeutics-crdl-capsovision-cv-petmed-express-pets https://www.stockstelegraph.com/3-stocks-building-momentum-behind-the-scenes-verrica-pharmaceuticals-vrca-fennec-pharmaceuticals-fenc-cardiol-therapeutics-crdl https://www.stockstelegraph.com/3-stocks-showing-promising-setups-teck-resources-teck-cardiol-therapeutics-crdl-joint-jynt https://www.stockstelegraph.com/unitil-corporation-utl-analyst-rating-changes-to-hold-with-target-price-of-54 https://www.stockstelegraph.com/twist-bioscience-corporation-twst-receives-outperform-rating-with-a-price-target-of-70 https://www.stockstelegraph.com/tractor-supply-company-tsco-analyst-upgrade-to-neutral-signals-cautious-optimism https://www.stockstelegraph.com/roblox-corporation-rblx-receives-neutral-rating-from-piper-sandler-target-price-reflects-upside-potential https://www.stockstelegraph.com/grupo-aeroportuario-del-pacifico-pac-receives-outperform-rating-with-upside-potential https://www.stockstelegraph.com/inspire-medical-systems-inc-insp-piper-sandler-downgrades-to-neutral-amidst-mixed-performance https://www.stockstelegraph.com/ies-holdings-inc-iesc-analyst-holds-steady-with-price-target-of-700 https://www.stockstelegraph.com/first-solar-inc-fslr-receives-buy-rating-with-upside-potential https://www.stockstelegraph.com/frequency-electronics-inc-feim-gets-buy-rating-with-short-term-upside-potential https://www.stockstelegraph.com/costamare-inc-cmre-analyst-upgrades-to-buy-with-solid-price-target https://www.stockstelegraph.com/chipotle-mexican-grill-inc-cmg-analysts-initiate-buy-rating-amid-target-price-upside https://www.stockstelegraph.com/cogent-communications-holdings-inc-ccoi-upgraded-to-overweight-by-jp-morgan-a-look-at-investment-potential https://www.stockstelegraph.com/banco-macro-s-a-bma-analyst-upgrades-rating-to-buy-with-22-upside-potential https://www.stockstelegraph.com/ballard-power-systems-inc-bldp-analyst-upgrade-to-buy-signals-potential-upside https://www.stockstelegraph.com/3-stocks-that-could-gain-steam-quickly-lyell-immunopharma-inc-lyel-cardiol-therapeutics-crdl-edap-tms-sa-edap https://www.stockstelegraph.com/3-stocks-flashing-bullish-signals-cardiol-therapeutics-crdl-amarin-amrn-atossa-therapeutics-atos https://www.stockstelegraph.com/3-stocks-that-could-climb-higher-soon-electromed-elmd-seres-therapeutics-mcrb-cardiol-therapeutics-crdl https://www.stockstelegraph.com/ufp-industries-inc-ufpi-receives-outperform-rating-with-upside-potential https://www.stockstelegraph.com/repay-holdings-corporation-rpay-receives-equal-weight-rating-from-stephens-co-signals-caution-for-investors https://www.stockstelegraph.com/vital-farms-inc-vitl-receives-neutral-rating-from-da-davidson-amidst-turbulent-performance https://www.stockstelegraph.com/the-trade-desk-inc-ttd-receives-neutral-rating-from-wedbush-analyst-alicia-reese https://www.stockstelegraph.com/the-toronto-dominion-bank-td-upgraded-to-sector-outperform-with-strong-upside-potential https://www.stockstelegraph.com/safehold-inc-safe-analyst-upgrades-to-sector-perform-amid-price-target-potential https://www.stockstelegraph.com/advanced-micro-devices-inc-amd-hsbc-assigns-hold-rating-amidst-market-fluctuations https://www.stockstelegraph.com/agilon-health-inc-agl-downgraded-to-underweight-by-jp-morgan-investors-weigh-options https://www.stockstelegraph.com/prudential-financial-inc-pru-analyst-downgrade-signals-caution https://www.stockstelegraph.com/packaging-corporation-of-america-pkg-deutsche-bank-upgrades-to-buy-with-strong-upside-potential https://www.stockstelegraph.com/o-i-glass-inc-oi-receives-overweight-upgrade-from-wells-fargo-amid-potential-upside https://www.stockstelegraph.com/international-paper-company-ip-secures-overweight-rating-from-wells-fargo-growth-potential-ahead https://www.stockstelegraph.com/alphabet-inc-googl-analysts-assign-hold-rating-with-400-price-target https://www.stockstelegraph.com/globalfoundries-inc-gfs-receives-overweight-rating-target-price-of-80 https://www.stockstelegraph.com/casella-waste-systems-inc-cwst-analysts-raise-outlook-as-stock-offers-substantial-upside-potential https://www.stockstelegraph.com/celcuity-inc-celc-receives-buy-rating-from-hc-wainwright-signaling-strong-upside-potential https://www.stockstelegraph.com/alexandria-real-estate-equities-inc-are-rating-downgrade-signals-caution-amidst-mixed-performance https://www.stockstelegraph.com/airbnb-inc-abnb-receives-outperform-rating-with-price-target-of-180-from-oppenheimer https://www.stockstelegraph.com/3-stocks-that-may-be-ready-to-run-cardiol-therapeutics-crdl-gyre-therapeutics-gyre-nanobiotix-nbtx https://www.stockstelegraph.com/3-stocks-starting-to-turn-heads-nervgen-pharma-ngen-cardiol-therapeutics-crdl-assembly-biosciences-asmb https://www.stockstelegraph.com/3-stocks-worth-watching-for-a-breakout-auna-sa-auna-profound-medical-prof-cardiol-therapeutics-crdl https://www.stockstelegraph.com/siteone-landscape-supply-inc-site-receives-buy-rating-from-stifel-amidst-promising-price-target https://www.stockstelegraph.com/essex-property-trust-inc-ess-receives-overweight-upgrade-with-significant-upside-potential https://www.stockstelegraph.com/3-stocks-catching-traders-attention-now-surrozen-srzn-cardiol-therapeutics-crdl-koru-medical-systems-krmd https://www.stockstelegraph.com/3-stocks-poised-for-a-breakout-move-cardiol-therapeutics-crdl-carlsmed-carl-aardvark-therapeutics-aard